Book a Demo
Andrew Murray
Gray shield icon
Is this you?
Claim your profile.

Andrew Murray

Journalist

AS SEEN ON
Beat Magazine, Long View Publishing Co., Fox News Media, The Business Times, New Statesman

Preston's Summary

Andrew Murray is a journalist at various prominent outlets, including Yahoo News and FOX 5 DC. He specializes in a diverse range of topics, including government and politics, food and beverages, as well as travel and tourism, reflecting his passion for exploring the intersection of these themes. Andrew's work has been featured in numerous publications such as Medium, GlobalResearch, and Golf Digest ME, where he aims to inform and inspire his audience through insightful reporting.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Williamstown, Australia (Local)

Coverage Attributes:

Beta
Informative: 50 %
Opinion: 18 %
Data Driven: 13 %
Events: 7 %
Interviews Q&as: 5 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Beverage Production
  • Drinks & Spirits
  • Elections
  • Government
  • Politics
  • Public Policy
  • Food Manufacturing
  • Food Production
  • Food Safety

Pitching Insights

Andrew's coverage is heavily focused on politics, with particular attention to government announcements, exclusives, legal policy regulation, and citing data. This suggests that he would be most responsive to pitches related to political developments in the United States and exclusive information or expert insights into legal and regulatory matters.

While Andrew does cover a wide range of topics including food pairings, cooking tips, whisky, wine etc., the majority of his focus lies within political themes. Therefore, when reaching out with non-political topics such as food-related content or other subjects outside of politics and government regulations it's important to ensure their relevance or tie-in with current political affairs in order to maximize engagement from him.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Paul Wilson

Paul Wilson

Assistant Editor
******n@************com
Publications
The Scotsman, Miami Times, INC., The Herald Bulletin, Isle Of Wight News From On The Wight, BenefitsPRO
Most recent topics
Not enough data
Jake Evans

Jake Evans

Federal Political Reporter/ Producer
********ke@********au
Publications
Australian Broadcasting Corporation (ABC), West Midlands News, NEXT.io, CDC Gaming Reports
Most recent topics
Not enough data
Michael Murphy

Michael Murphy

Guides Writer
******l@*************.uk
Publications
National Post, Inc., Orlando Weekly, The Critic Magazine, UnHerd, NewsBreak
Most recent topics
Not enough data
Stephen Green

Stephen Green

Denver Editor
******ng@*********om
Publications
PJTV, countrytown.com, TheMusic.com.au
Most recent topics
Not enough data
Tim James

Tim James

Wine Commentator
*******es@*****a
Publications
Winemag.co.za
Most recent topics
Not enough data
Chris Blackhurst

Chris Blackhurst

Publications
The Independent, Evening Standard, The National News, The Independent, NewsBreak
Most recent topics
Not enough data

Articles

BMJ

GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review

GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review

By: Sharon Madigan, Christopher Gee, Ronan Kearney, Scott Morrison, Andrew Murray, Conor Mccann, Phil Walmsley, Swati Chopra, Nick Clement, Andrew Hall

Objective To map current strategies for weight loss in hip and knee osteoarthritis (OA), with emphasis on the emerging role of glucagon-like peptide-1 receptor agonists (GLP-1-RAs) as tools in achieving weight loss and impacting symptoms, disease progression and perioperative outcomes in individuals with obesity.Design Scoping review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) framework and methodological guidance from the Joanna Briggs Institute and Arksey and O’Malley.Data sources PubMed, Web of Science, Directory of Open Access Journals, Scopus, ProQuest Central (1 January 2010 to 18 August 2025).Eligibility criteria Included studies focused on adults (≥18 years) with obesity and hip or knee OA, examined weight-loss strategies (nutritional, physical activity, surgical or pharmacological) including GLP-1-RAs.Results Of 199 included studies, 36 (18.1%) directly assessed GLP-1-RAs and of these, 14/36 (38.9%) reported original data. Evidence was heavily skewed towards knee OA, with limited hip-specific data. Descriptive analysis revealed a narrow geographical distribution of studies and a rapidly increasing focus on GLP-1-RAs; most studies involving GLP-1-RAs (29/36, 80.6%) were published between 2024 and 2025 and were of a low level of evidence (19/36, 52.8% level 5). Randomised and cohort data in knee OA indicate that GLP-1-RAs are associated with substantial weight loss, with accompanying improvements in pain/function and reduced progression to arthroplasty. In contrast, evidence in hip OA is sparse with weaker associations.Conclusion GLP-1-RAs represent a promising adjunct for managing individuals with OA complicated by obesity. Until further evidence emerges, GLP-1-RAs should be integrated into supervised, multimodal musculoskeletal care rather than used as standalone weight-loss agents.No data are available.

© 2026 Intelligent Relations